Projects search

• Keywords: supramolecular drugs ×

Change search criteria ↓

Search results

8 projects found matching your search criteria:

1. 1. Injectable biodegradable local drug delivery system supramolecularly cross-linked in situ with controlled drug release

   Principal investigator: dr hab. Piotr Kurcok

   Centrum Materiałów Polimerowych i Węglowych PAN

   Call: OPUS 9, Panel: ST5

2. 2. Supramolecular compounds and their complexes with carbon nanotubes as potential systems for targeted delivery of drugs

   Principal investigator: dr Anna Jagusiak

   Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

   Call: SONATA 11, Panel: NZ1

3. 3. Enzyme Responsive Nanoscale Supramolecular Capsules with Application in Anticancer Drug Delivery

   Principal investigator: dr Venkateswarulu Mangili

   Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Zaawansowanych Technologii

   Call: POLONEZ BIS 2, Panel: ST4

4. 4. Supramolecular nanoparticles able to block calcium channels in cancer cells

   Principal investigator: dr hab. Marek Brzeziński

   Centrum Badań Molekularnych i Makromolekularnych PAN

   Call: SONATA BIS 14, Panel: ST11

5. 5. Stimuli-responsive anion transporters for targeted drug delivery

   Principal investigator: dr hab. Michał Jan Chmielewski

   Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

   Call: OPUS 26, Panel: ST5

6. 6. Click chemistry in microfluidic channels for the construction of nanomaterials against drug-resistant microbes.

   Principal investigator: dr hab. Marek Brzeziński

   Centrum Badań Molekularnych i Makromolekularnych PAN

   Call: PRELUDIUM BIS 5, Panel: ST11

7. 7. Supramolecular complexes of cucurbiturils as crystalline functional materials: synthesis, studies of structure and prope…

   Principal investigator: dr Oksana Danylyuk

   Instytut Chemii Fizycznej Polskiej Akademii Nauk

   Call: SONATA 2, Panel: ST5

8. 8. Study of supramolecular interaction between the xenoandrogens and androgen receptor

   Principal investigator: dr hab. Michał Piotr Marszałł

   Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

   Call: SONATA 2, Panel: NZ7